Literature DB >> 22395314

Molecular oxygen sensing: implications for visceral surgery.

Judit Kiss1, Johanna Kirchberg, Martin Schneider.   

Abstract

BACKGROUND: Since mammalian cells rely on the availability of oxygen, they have devised mechanisms to sense environmental oxygen tension, and to efficiently counteract oxygen deprivation (hypoxia). These adaptive responses to hypoxia are essentially mediated by hypoxia inducible transcription factors (HIFs). Three HIF prolyl hydroxylase enzymes (PHD1, PHD2 and PHD3) function as oxygen sensing enzymes, which regulate the activity of HIFs in normoxic and hypoxic conditions. Many of the compensatory functions exerted by the PHD-HIF system are of immediate surgical relevance since they regulate the biological response of ischemic tissues following ligation of blood vessels, of oxygen-deprived inflamed tissues, and of tumors outgrowing their vascular supply.
PURPOSE: Here, we outline specific functions of PHD enzymes in surgically relevant pathological conditions, and discuss how these functions might be exploited in order to support the treatment of surgically relevant diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22395314     DOI: 10.1007/s00423-012-0930-z

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  68 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.

Authors:  Heidi Högel; Krista Rantanen; Terhi Jokilehto; Reidar Grenman; Panu M Jaakkola
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

Review 3.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

4.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

5.  Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.

Authors:  Melanie L Hart; Almut Grenz; Iris C Gorzolla; Jens Schittenhelm; Julee H Dalton; Holger K Eltzschig
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

Review 6.  Hepatic ischemia-reperfusion injury.

Authors:  F Serracino-Inglott; N A Habib; R T Mathie
Journal:  Am J Surg       Date:  2001-02       Impact factor: 2.565

7.  Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model.

Authors:  W M Bernhardt; U Gottmann; F Doyon; B Buchholz; V Campean; J Schödel; A Reisenbuechler; S Klaus; M Arend; L Flippin; C Willam; M S Wiesener; B Yard; C Warnecke; K-U Eckardt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

Review 8.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

Review 9.  Hypoxia and gastrointestinal disease.

Authors:  Cormac T Taylor; Sean P Colgan
Journal:  J Mol Med (Berl)       Date:  2007-11-20       Impact factor: 4.599

10.  Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis.

Authors:  Carole Peyssonnaux; Pilar Cejudo-Martin; Andrew Doedens; Annelies S Zinkernagel; Randall S Johnson; Victor Nizet
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

View more
  6 in total

Review 1.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

2.  Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy.

Authors:  Martin Mollenhauer; Judit Kiss; Johanna Dudda; Johanna Kirchberg; Nuh Rahbari; Praveen Radhakrishnan; Thomas Niemietz; Vanessa Rausch; Jürgen Weitz; Martin Schneider
Journal:  Langenbecks Arch Surg       Date:  2012-09-11       Impact factor: 3.445

Review 3.  Osteoarthritis pathogenesis: a review of molecular mechanisms.

Authors:  Bingjiang Xia; Jushi Zhang; Songfeng Hu; Hongting Jin; Peijian Tong
Journal:  Calcif Tissue Int       Date:  2014-10-14       Impact factor: 4.333

Review 4.  Genomic insights into ayurvedic and western approaches to personalized medicine.

Authors:  Bhavana Prasher; Greg Gibson; Mitali Mukerji
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

5.  Construction of a recombinant eukaryotic expression vector containing PHD3 gene and its expression in HepG2 cells.

Authors:  Qi-Lian Liang; Zhou-Yu Li; Yuan Zhou; Qiu-Long Liu; Wen-Ting Ou; Zhi-Gang Huang
Journal:  J Exp Clin Cancer Res       Date:  2012-08-17

Review 6.  Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challenges.

Authors:  Jonathan Michael Harnoss; Moritz Johannes Strowitzki; Praveen Radhakrishnan; Lisa Katharina Platzer; Julian Camill Harnoss; Thomas Hank; Jun Cai; Alexis Ulrich; Martin Schneider
Journal:  Hypoxia (Auckl)       Date:  2015-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.